Real-World Medication Adherence Trajectories to Nintedanib among Idiopathic Pulmonary Fibrosis Patients

First published 27/08/2021

Last updated 16/10/2026

EU PAS number:

EUPAS42653

Study

Finalised

Download as PDF

Documents

Study protocol

Updated protocol

1199-0471_Prot_SAP_redacted.pdf

First published: 21/09/2026

English (304.46 KB - PDF) View document

Study results

1199-0471_Synopsis.pdf

English (182.47 KB - PDF) View document

Study report

No information provided.

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

Real-World Medication Adherence Trajectories to Nintedanib among Idiopathic Pulmonary Fibrosis Patients

Secondary tabs

Share this page